Overview

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

Status:
Recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This study is a prospective, open-label, phase I design.
Phase:
Phase 1
Details
Lead Sponsor:
Medical College of Wisconsin
Treatments:
Capecitabine
Oxaliplatin